Health Care: Drugs

Alkermes PLC (ALKS: NASDAQ)

$62.26 n/a | n/a%
04/24/15 - 03:59 PM ET
Company Income Statement
Dec 2014 Dec 2013 Mar 2013 Mar 2012
Sales 618.79M 432.91M 575.55M 389.98M
Cost of Sales 135.90M 134.31M 138.57M 105.05M
Gross Operating Profit 482.89M 298.60M 436.98M 284.93M
Selling, General, and Administrative Expenses 199.90M 116.56M 125.76M 137.63M
Research & Development 272.04M 128.12M 140.01M 141.89M
Operating Income before D & A (EBITDA) 10.94M 53.92M 171.21M 5.40M
Depreciation & Amortization 98.09M 38.43M 73.75M 93.68M
Interest Income 1.97M 711.00K 841.00K 1.52M
Other Income - Net 84.57M -429.00K 1.78M 484.00K
Special Income / Charges 0.00 0.00 -3.35M 0.00
Total Income Before Interest Expenses (EBIT) -599.00K 15.78M 84.44M -86.28M
Interest Expense 13.43M 10.38M 48.99M 28.11M
Pre-Tax Income -14.03M 5.40M 35.44M -114.39M
Income Taxes 16.03M -12.25M 10.46M -714.00K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -30.06M 17.65M 24.98M -113.68M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -30.06M 17.65M 24.98M -113.68M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -30.06M 17.65M 24.98M -113.68M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-30.06M 17.65M 40.63M -113.68M
Preferred Dividends
Net Income Available To Common -30.06M 17.65M 24.98M -113.68M
Basic EPS from Continuing Ops. -0.21 0.13 0.19 -0.99
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.21 0.13 0.19 -0.99
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.21 0.13 0.19 -0.99
Basic Normalized Net Income/Share -0.21 0.13 0.31 -0.99
EPS fr Continuing Ops. -0.21 0.12 0.18 -0.99
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.21 0.12 0.18 -0.99
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.21 0.12 0.18 -0.99
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.21 0.12 0.30 -0.99
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ALKS

Latest ALKS Headlines from TheStreet

More Financial News for ALKS

Press Releases for ALKS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter